Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10156585 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 6 Pages |
Abstract
MBC is a rare second malignancy among childhood cancer survivors. Receipt of radiation therapy is a recognized risk factor, but more data about eventual genetic mutations are necessary. Regular screening based only on a history of radiation therapy is not recommended; however, attention must be given in the case of suspicious symptoms.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Charlotte MD, Rodrigue S. MD, Angela MD, Giao MSc, Vincent MD, Brice MD, Chiraz MD, Nadia MD, Carole MD, Helène MD, Cristina MD, Damien MD, Ibrahima PhD, Florent PhD,